Table 3.
Management of COVID-19 and related complications - all cases (n = 31 016)
| Characteristics of all pregnant women |
Total # of studies | Total events/participants | Pooled proportion (%) (95% CI) | Heterogeneity (I2%) | |
|---|---|---|---|---|---|
| Antibiotic |
14 |
448/1140 |
45.8 (27.0 to 65.3) |
97.5 |
|
| Antiviral |
17 |
514/1742 |
33.4 (16.3 to 53.1) |
98.4 |
|
| Hydroxychloroquine |
11 |
305/877 |
41.3 (21.0 to 63.1) |
97.2 |
|
| Anticoagulants |
5 |
282/1219 |
50.6 (12.8 to 88.0) |
99.4 |
|
| Corticosteroids |
8 |
73/425 |
14.7 (8.0 to 22.8) |
75.5 |
|
| Immunotherapy |
6 |
45/827 |
16.2 (1.7 to 39.7) |
96.6 |
|
| Plasma therapy |
4 |
183/385 |
22.5 (0.0 to 79.3) |
99.2 |
|
| Oxygen therapy |
20 |
321/1812 |
20.6 (11.0 to 32.2) |
96.3 |
|
| ICU admission |
22 |
717/27 865 |
7.2 (4.8 to 9.9) |
94.1 |
|
| ICU management | Mechanical ventilation |
20 |
282/4048 |
7.7 (3.7 to 12.9) |
95.8 |
| Non-invasive ventilation |
5 |
268/1463 |
15.1 (3.3 to 32.4) |
97.0 |
|
| ECMO |
6 |
31/24937 |
0.3 (0.0 to 1.2) |
79.8 |
|
| ARDS |
4 |
30/522 |
10.0 (0.1 to 25.3) |
91.6 |
|
| Maternal death | 14 | 208/27 680 | 2.0 (0.8 to 3.8) | 94.6 | |
ARDS – acute respiratory distress syndrome, CI – confidence interval, COVID – coronavirus disease, ECMO – extracorporeal membrane oxygenation, ICU – intensive care unit, MODS – multiple organ dysfunction syndrome